Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?

被引：7
|
作者：
McCloskey, E. V. [1 ,2 ]
Chotiyarnwong, P. [1 ,3 ]
Harvey, N. C. [4 ]
Lorentzon, M. [5 ,6 ]
Kanis, J. A. [2 ,6 ]
机构：
[1] Univ Sheffield, Dept Oncol & Metab, MRC Versus Arthrit Ctr Integrated Res Musculoskel, Mellanby Ctr Musculoskeletal Res, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Orthopaed Surg, Bangkok, Thailand
[4] Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England
[5] Univ Gothenburg, Gothenburg, Sweden
[6] Australian Catholic Univ, Melbourne, Vic, Australia
来源：
OSTEOPOROSIS INTERNATIONAL | 2022年 / 33卷 / 08期
关键词：
ESTROGEN PLUS PROGESTIN; BONE-MINERAL DENSITY; COST-EFFECTIVENESS; HIP FRACTURE; OLDER WOMEN; RANDOMIZED-TRIAL; DOUBLE-BLIND; PREVENTION; INTERVENTION; COMMUNITY;
D O I：
10.1007/s00198-022-06419-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1631 / 1637
页数：7
相关论文
共 50 条
  • [1] Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
    Chotiyarnwong, P.
    McCloskey, E. V.
    Harvey, N. C.
    Lorentzon, M.
    Prieto-Alhambra, D.
    Abrahamsen, B.
    Adachi, J. D.
    Borgstrom, F.
    Bruyere, O.
    Carey, J. J.
    Clark, P.
    Cooper, C.
    Curtis, E. M.
    Dennison, E.
    Diaz-Curiel, M.
    Dimai, H. P.
    Grigorie, D.
    Hiligsmann, M.
    Khashayar, P.
    Lewiecki, E. M.
    Lips, P.
    Lorenc, R. S.
    Ortolani, S.
    Papaioannou, A.
    Silverman, S.
    Sosa, M.
    Szulc, P.
    Ward, K. A.
    Yoshimura, N.
    Kanis, J. A.
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [2] Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis
    Long, Guanghua
    Liu, Chong
    Liang, Tuo
    Zhang, Zide
    Qin, Zhaojie
    Zhan, Xinli
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [3] Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
    Bilezikian, John P.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (02) : 14 - 21
  • [4] Parity and risk of hip fracture in postmenopausal women
    Kauppi, M.
    Heliovaara, M.
    Impivaara, O.
    Knekt, P.
    Jula, A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1765 - 1771
  • [5] Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold
    Wang, Y.
    Yu, S.
    Hsu, C.
    Tsai, C.
    Cheng, T.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (03) : 475 - 483
  • [6] Fracture risk assessment in postmenopausal women
    Hamdy, Ronald C.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (04) : 229 - 236
  • [7] Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies
    Wang, Q.
    Huang, Q.
    Zeng, Y.
    Liang, J. -j.
    Liu, S. -y.
    Gu, X.
    Liu, J. -a.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 319 - 330
  • [8] Clinical risk factors for fracture in postmenopausal osteoporotic women: A review of the recent literature
    LaFleur, Joanne
    McAdam-Marx, Carrie
    Kirkness, Carmen
    Brixner, Diana I.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (03) : 375 - 386
  • [9] Natto Intake is Inversely Associated with Osteoporotic Fracture Risk in Postmenopausal Japanese Women
    Kojima, Akane
    Ikehara, Satoyo
    Kamiya, Kuniyasu
    Kajita, Etsuko
    Sato, Yuho
    Kouda, Katsuyasu
    Tamaki, Junko
    Kagamimori, Sadanobu
    Iki, Masayuki
    JOURNAL OF NUTRITION, 2020, 150 (03) : 599 - 605
  • [10] High osteoporotic fracture risk and CVD risk co-exist in postmenopausal women
    Makovey, Joanna
    Macara, Monique
    Chen, Jian Sheng
    Hayward, Christopher S.
    March, Lyn
    Sambrook, Philip N.
    BONE, 2013, 52 (01) : 120 - 125
12345